期刊文献+

重型再生障碍性贫血造血干细胞移植治疗的中医内涵探微 被引量:10

Significance of TCM in the treatment of acute aplastic anemia with hematopoietic stem cell transplantation
原文传递
导出
摘要 造血干细胞移植是重型再生障碍性贫血(急性"髓劳")的重要治疗手段之一,中医药在促进植入、刺激造血、调节免疫等方面具有重要的意义,近年来被不断实践应用。文章结合古籍、文献及临床实践经验对干细胞移植的整个过程进行了中医理论阐述,认为"髓劳"即"精髓劳伤",本于肾元亏虚。"移植物"按功能不同可分为"髓阴""髓阳",造血干细胞移植即为直补"精髓"的过程,"髓阴""髓阳"的交互生化以及制约权衡决定了移植物抗宿主病的发生与否及严重程度。结合移植过程中气阴两虚-阴阳两虚-脾肾阳虚的证侯演变特点,分期论治的同时贯穿"痰瘀同治"是可行的治疗方案。 Recently,traditional Chinese medicine(TCM) has played important roles in the process of hematopoietic stem cell transplantation(HSCT),one of important therapeutic program in acute aplastic anemia,especially in transplantation,hematopoiesis and immune regulation.This article is mainly on explaining the TCM theory during the process of SCT.‘Suilao' means the exhaustion of marrow,which attributes to the dei ciency of kidney.‘Graft' could be divided in to ‘Suiyin' and ‘Suiyang' according to the function under the theory of TCM.Transplantation means to reinforce the marrow,and the interaction and interlimitation of ‘Suiyin' and ‘Suiyang' determines the incidence and severity of graft versus host disease(GVHD).Combined with the characteristic of sydrome evolution from dei ciency of both qi and yin to dei ciency of both yin and yang to yan dei ciency of spleen and kidney,the treatment based on stage differentiation and ‘removing phlegm and blood-stasis' according the syndrome evolution characteristics may the feasible protocol.
机构地区 浙江省中医院
出处 《中华中医药杂志》 CAS CSCD 北大核心 2016年第9期3457-3460,共4页 China Journal of Traditional Chinese Medicine and Pharmacy
基金 国家中医药管理局中医药行业科研专项资助项目(No.201107001,No.201407001) 国家中医临床研究基地业务建设科研专项资助项目(No.JDZX2012178) 浙江省中医药科学研究基金项目(No.2016ZA069)~~
关键词 再生障碍性贫血 髓劳 造血干细胞移植 中医内涵 Aplastic anemia Suilao Hematopoietic stem cell transplantation Connotation in TCM
  • 相关文献

参考文献6

二级参考文献34

  • 1虞荣喜,周郁鸿,林圣云,郑智茵,罗秀素,陈均法,叶宝东,楼海英.人类白细胞抗原半相合亲缘性骨髓移植联合中药治疗白血病的临床观察[J].中国中西医结合杂志,2006,26(7):600-603. 被引量:6
  • 2中华血液学会.第四届全国再生障碍性贫血学术会议纪要-再生障碍性贫血诊断标准与疗效标准.中华血液学杂志,1987,8(8):486-486.
  • 3Bacigalupo A.Treatment strategies for patients with severe aplastic anemia. Bone Marrow Transplant,2008,42 Suppl 1:42-44.
  • 4Young N S.Pathophysiologic mechanisms in acquired aplastic anemia. Hematology Am Soc Hematol Educ Program,2006:72-77.
  • 5Park Y B, Lee J W,Cho B S,et al. Incidence and Etiology of Overt Gastrointestinal Bleeding in Adult Patients with Aplastic Anemia. Dig Dis Sci,2009:23.
  • 6Gonz a lez-Duarte A,Garc i a-Ramos GS,Vald e s-Ferrer SI,et al. Clinical description of intracranial hemorrhage associated with bleeding disorders. J Stroke Cerebrovasc Dis,2008,17(4):204-207.
  • 7国家中医药管理局医政司.22个专业95个病种中医诊疗方案(合订本)[M].北京.中国中医药出版社,2011,298-300.
  • 8Dufour C, Svahn J, Bacigalupo A, et al. Front-line immu- nosuppressive treatment of acquired aplastic anemia [ J ]. Bone Marrow Transplant, 2013,48 (2) : 174 - 177.
  • 9Kikuchi A, Yabe H, Kato K, et al. Long-term outcome of childhood aplastic anemia patients who underwent allogene- ic hematopoietic SCT from an HLA-matched sibling donor in Japan [ J ]. Bone Marrow Transplant, 2013,48 (5) : 657 - 660.
  • 10夏乐三.近年来国内对再生障碍性贫血的研究概况.中级医刊,1964,3:169-172.

共引文献55

同被引文献141

引证文献10

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部